Breaking News Instant updates and real-time market news.

GBT

Global Blood Therapeutics

$18.65

0.6 (3.32%)

09:12
11/30/16
11/30
09:12
11/30/16
09:12

Global Blood Therapeutics granted Orphan Drug Designation by EMA for GBT440

Blood Therapeutics announced that the European Commission, acting on a positive recommendation from the Committee for Orphan Medicinal Products, or COMP, of the European Medicines Agency, has designated GBT440 as an orphan medicinal product for the treatment of sickle cell disease.

  • 03

    Dec

  • 14

    Dec

  • 15

    Dec

  • 19

    Dec

GBT Global Blood Therapeutics
$18.65

0.6 (3.32%)

09/30/16
WELS
09/30/16
INITIATION
WELS
Outperform
Global Blood Therapeutics initiated with an Outperform at Wells Fargo
Wells Fargo analyst Jim Birchenough started Global Blood Therapeutics with an Outperform rating and $75-$81 price target range. The analyst has a positive outlook for the company's hemoglobin modifier GBT440 in Sickle Cell Disease. He views GBT440 as a best-in-class hemoglobin modifier and estimates peak sales at $2.7B.
10/25/16
COWN
10/25/16
NO CHANGE
Target $83
COWN
Outperform
Global Blood Therapeutics price target raised to $83 from $80 at Cowen
Cowen analyst Ritu Baral raised his price target on Global Blood Therapeutics to $83 from $80 after the company reached a deal with the FDA regarding the design of its pivotal trial for GBT440 for sickle cell. Baral reiterated his Outperform rating on Global Therapeutics shares.
11/01/16
ROTH
11/01/16
INITIATION
Target $47
ROTH
Buy
Global Blood Therapeutics initiated with a Buy at Roth Capital
Roth Capital analyst Mark Breidenbach started Global Blood Therapeutics with a Buy rating and $47 price target, saying it represents an attractive investment opportunity as he believes its lead product, GBT440, has the potential to improve the standard of care for patients who suffer from Sickle Cell Anemia.
11/04/16
ROTH
11/04/16
NO CHANGE
Target $47
ROTH
Buy
Global Blood weakness on ASH abstracts unjustified, says Roth Capital
Roth Capital analyst Mark Breidenbach believes Global Blood Therapeutics' GBT440 has the potential to markedly improve the standard of care for patients who suffer from sickle cell anemia. With an upcoming readout expected at ASH that could significantly de-risk the company's planned pivotal trial, the analyst believes Global Blood Therapeutics represents an "excellent investment opportunity." Further, Breidenbach notes that the shares' weakness following the publication of abstracts for the upcoming 2016 ASH meeting seems to be unjustified. He says Global Blood Therapeutics remains a Focus Pick, and reiterates a Buy rating and $47 price target on the shares.

TODAY'S FREE FLY STORIES

BPMC

Blueprint Medicines

$27.01

-0.99 (-3.54%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Blueprint Medicines to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

CBS

CBS

$60.18

-0.39 (-0.64%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
CBS management to meet with JPMorgan »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 12

    Dec

PLNT

Planet Fitness

$20.02

0.03 (0.15%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Planet Fitness management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 09

    Jan

RMBS

Rambus

$12.76

0.09 (0.71%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Rambus participates in a conference call with JPMorgan »

JPMorgan Alternative…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
UBS economists and strategists hold an analyst/industry conference call »

U.S. Equity &…

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
ISM Non-Mfg Index Composite to be reported at 10:00 »

November ISM Non-Mfg…

JCI

Johnson Controls

$45.32

-0.41 (-0.90%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Johnson Controls to hold a meeting »

Strategic Review &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

CNDT

Conduent

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Conduent to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

VCRA

Vocera

$17.96

0.07 (0.39%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Vocera management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Barclays commodities/energy analysts hold an analyst/industry conference call »

Commodities Analysts…

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

Chicago Federal Reserve…

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Juno Therapeutics to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

TKPPY

Technip

$17.80

0.45 (2.59%)

, FTI

FMC Technologies

$35.60

0.9 (2.59%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
FMC Technologies to host special shareholder meeting »

Special Shareholder…

TKPPY

Technip

$17.80

0.45 (2.59%)

FTI

FMC Technologies

$35.60

0.9 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

TGTX

TG Therapeutics

$5.50

0.05 (0.92%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
TG Therapeutics to hold an investor and analyst reception »

In connection with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
JPMorgan Euro & global equity strategist holds analyst/industry conference call »

European & Global…

CSV

Carriage Services

$27.50

0.21 (0.77%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Carriage Services management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

Chicago Federal Reserve…

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

GNMSF

Genmab

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Genmab to hold data review meeting »

Management discusses data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

RHHBY

Roche

$27.20

-0.1 (-0.37%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Roche to hold an analyst meeting »

Analyst Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

BSFT

BroadSoft

$40.30

-0.35 (-0.86%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
BroadSoft to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

CLF

Cliffs Natural

$9.56

0.32 (3.46%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Cliffs Natural management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.